Low-Grade Fibromyxoid Sarcoma and Related Subtypes: A Systematic Review and Pooled Analysis of 773 Cases
Cancers · 23.01.2026 · 18 (3) · 364
DOI: 10.3390/cancers18030364 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.01.2026. Verfasst von Gitte G J Krebbekx und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Sports Medicine, Amsterdam Movement Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Am…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Low-grade fibromyxoid sarcoma (LGFMS) is a rare malignant fibroblastic tumor that often appears deceptively benign. Accurate diagnosis is challenging due to its variable morphology and low mitotic activity. This systematic review provides a comprehensive overview of LGFMS and its subtypes.
Methods
A systematic search of PubMed and Embase up to September 2025 identified 273 studies, complemented by four institutional cases from Amsterdam UMC. Individual patient data were pooled to analyze clinical presentation, diagnostic approaches, treatment modalities, and outcomes.
Results
In total, 773 patients were included, with a median age of 35 years and equal gender distribution. Tumors were predominantly deep-seated (80%), most commonly located in the thigh or pelvis. MUC4 positivity (96%) and FUS-CREB3L2 fusion (47%) were the most consistent diagnostic markers. Surgery was the mainstay of treatment (98%), with R0 resection achieved in 36% of cases and R1 in 15%. Adjuvant therapies, including chemotherapy and radiotherapy, were rarely used and showed limited efficacy. After a median follow-up of 3.0 years, 19% developed local recurrence and 21% developed metastases. R0 resections were associated with significantly better recurrence-free survival than R1 resection (p < 0.05).
Conclusions
LGFMS exhibits indolent histology but potential for late recurrence and metastasis, warranting prolonged radiological follow-up and multicenter studies to evaluate adjuvant strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery and Sports Medicine, Amsterdam Movement Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Amsterdam Movement Sciences, Rehabilitation & Development, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Department of Pathology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Amsterdam Institute for Immunology and Infectious Diseases, Cancer Immunology, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Department of Radiology and Nuclear Medicine, Amsterdam Movement Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
ORCID-Profile: Gitte G J Krebbekx, Elisabeth A Kleine, Donner, Floortje G M Verspoor
Zitieren
APA
Krebbekx, G. G. J., Kleine, E. A., Savci-Heijink, C. D., Meijer, D. T., Donner, Hemke, R., & Verspoor, F. G. M. (2026). Low-Grade Fibromyxoid Sarcoma and Related Subtypes: A Systematic Review and Pooled Analysis of 773 Cases. Cancers, 18(3), 364. https://doi.org/10.3390/cancers18030364
Vancouver
Krebbekx GGJ, Kleine EA, Savci-Heijink CD, Meijer DT, Donner, Hemke R, et al. Low-Grade Fibromyxoid Sarcoma and Related Subtypes: A Systematic Review and Pooled Analysis of 773 Cases. Cancers. 2026;18(3):364. doi:10.3390/cancers18030364
BibTeX
@article{Krebbekx2026,
author = {Krebbekx, Gitte G J and Kleine, Elisabeth A and Savci-Heijink, C Dilara and Meijer, Diederik T and Donner and Hemke, Robert and Verspoor, Floortje G M},
title = {Low-Grade Fibromyxoid Sarcoma and Related Subtypes: A Systematic Review and Pooled Analysis of 773 Cases},
journal = {Cancers},
year = {2026},
volume = {18},
number = {3},
pages = {364},
doi = {10.3390/cancers18030364}
}
EUVIMED